Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Issues surrounding prenatal genetic testing for achondroplasia.

Holly C Gooding1, Karina Boehm, Richard E Thompson

  • 1Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20824, USA. barbarab@nhgri.nih.gov

Prenatal Diagnosis
|October 16, 2002
PubMed
Summary

Most people are aware of prenatal genetic testing for achondroplasia, but few use it. Affected individuals show greater interest in prenatal testing than relatives, influenced by personal views on abortion and diagnosis importance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engaging Medical Students in Adolescent Health Research: An Innovative Summer Rotation Model.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2026
Same author

Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney Failure: The RAFT Clinical Trial.

JAMA·2026
Same author

Associations between screen time and dietary intake among early adolescents: a prospective cohort study.

Pediatric research·2026
Same author

A Large, Diverse, Urban Cardiovascular Health e-Cohort in Childhood and Adolescence: Protocol for the Young Hearts Study.

JMIR research protocols·2026
Same author

What Teens Hear and How They React: Adolescent Perspectives on Substance Use, Sexual Risk, and Sexual Violence Prevention in Primary Care.

Behavioral sciences (Basel, Switzerland)·2026
Same author

Functional and Patient-Reported Outcomes in the Atorvastatin versus Placebo Trial of Hemorrhagic Cerebral Cavernous Malformations: An Exploratory Study.

Cerebrovascular diseases (Basel, Switzerland)·2026

Area of Science:

  • Medical Genetics
  • Reproductive Health
  • Human Genetics

Background:

  • Achondroplasia, the most common form of dwarfism, results from mutations in the fibroblast growth factor receptor 3 gene.
  • Prenatal genetic testing for achondroplasia has been commercially available since 1994.
  • Understanding awareness, interest, and utilization of this testing is crucial for reproductive decision-making.

Purpose of the Study:

  • To assess awareness of prenatal genetic testing for achondroplasia.
  • To gauge interest in using prenatal genetic testing among affected individuals and their relatives.
  • To explore factors influencing reproductive choices related to achondroplasia diagnosis.

Main Methods:

  • Surveys were administered to individuals with achondroplasia (n=189) and their average-statured relatives (n=136).

Related Experiment Videos

  • Data collected focused on awareness, interest, and past utilization of prenatal genetic testing.
  • Analysis explored correlations between attitudes, beliefs, and testing interest.

    • Main Results:

    • High awareness of prenatal testing was reported, but less than 10% had utilized it.
    • Individuals with achondroplasia expressed significantly higher interest (62%) compared to relatives (28%).
    • Interest in testing for lethal homozygous achondroplasia and views on abortion strongly correlated with overall interest in prenatal diagnosis.

    Conclusions:

    • Attitudes and beliefs significantly shape reproductive decisions concerning achondroplasia.
    • Findings offer valuable insights for genetic counseling and educational strategies for families and healthcare providers.
    • Personal perspectives on abortion and the importance of diagnosis influence the uptake of prenatal genetic testing.